BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25492391)

  • 1. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
    J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD; Richter SS; Cober ED; van Duin D
    Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
    Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
    PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
    Qureshi ZA; Syed A; Clarke LG; Doi Y; Shields RK
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3100-4. PubMed ID: 24637691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
    Hauck C; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Scalera NM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Microbiol Infect; 2016 Jun; 22(6):513-9. PubMed ID: 26850824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
    Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
    Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
    van Duin D; Cober ED; Richter SS; Perez F; Cline M; Kaye KS; Kalayjian RC; Salata RA; Evans SR; Fowler VG; Bonomo RA
    Clin Microbiol Infect; 2014 Dec; 20(12):O1117-20. PubMed ID: 24931918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
    Vergadi E; Bitsori M; Maraki S; Galanakis E
    J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.
    Messina JA; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Scalera NM; Doi Y; Kaye KS; Evans S; Bonomo RA; Fowler VG; van Duin D;
    Infect Control Hosp Epidemiol; 2016 Mar; 37(3):281-8. PubMed ID: 26686227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
    Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):942-8. PubMed ID: 25990806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
    J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
    Bleumin D; Cohen MJ; Moranne O; Esnault VL; Benenson S; Paltiel O; Tzukert K; Mor-Yosef Levi I; Ben-Dov IZ; Levi R; Bloch A; Haviv YS
    J Infect; 2012 Oct; 65(4):318-25. PubMed ID: 22722020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
    Hu Y; Ping Y; Li L; Xu H; Yan X; Dai H
    J Infect Dev Ctries; 2016 Mar; 10(3):208-13. PubMed ID: 27031451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.